![Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry - Speed - 2021 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry - Speed - 2021 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cfd91597-dd2d-4310-8267-896c5b5de32c/rth2.v5.8.cover.jpg?trick=1693437682371)
Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry - Speed - 2021 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
![PDF) The implementation of Systems-Theoretic Accident Model and Processes on standardization of safety in mechatronic systems (humanoids) PDF) The implementation of Systems-Theoretic Accident Model and Processes on standardization of safety in mechatronic systems (humanoids)](https://i1.rgstatic.net/publication/261361680_The_implementation_of_Systems-Theoretic_Accident_Model_and_Processes_on_standardization_of_safety_in_mechatronic_systems_humanoids/links/59a81a77aca272d1b84aebb8/largepreview.png)
PDF) The implementation of Systems-Theoretic Accident Model and Processes on standardization of safety in mechatronic systems (humanoids)
![COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12959-018-0176-2/MediaObjects/12959_2018_176_Fig2_HTML.png)
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text
![PDF) The Need for Stress Relieving and Self-Confidence-Boosting Sessions in EFL Teacher Training Courses to Avoid EFL Teacher Burnout PDF) The Need for Stress Relieving and Self-Confidence-Boosting Sessions in EFL Teacher Training Courses to Avoid EFL Teacher Burnout](https://i1.rgstatic.net/publication/215805384_The_Need_for_Stress_Relieving_and_Self-Confidence-Boosting_Sessions_in_EFL_Teacher_Training_Courses_to_Avoid_EFL_Teacher_Burnout/links/000ba57252e8b771dd8fb220/largepreview.png)
PDF) The Need for Stress Relieving and Self-Confidence-Boosting Sessions in EFL Teacher Training Courses to Avoid EFL Teacher Burnout
![COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12959-018-0176-2/MediaObjects/12959_2018_176_Fig1_HTML.png)
COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study | Thrombosis Journal | Full Text
![ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months - ScienceDirect ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049384820305053-gr1.jpg)
ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months - ScienceDirect
![How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study - Research and Practice in Thrombosis and Haemostasis How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/attachment/92af8a43-0e80-4e0f-bb46-8d42ca3d4e32/gr1_lrg.jpg)